gabexate   Click here for help

GtoPdb Ligand ID: 7863

Approved drug
gabexate is an approved drug (Japan)
Compound class: Synthetic organic
Comment: Gabexate (as the mesylate) is an inhibitor of trypsin-like serine proteases and is used in the treatment of pancreatitis, disseminated intravascular coagulation and as a regional anticoagulant for hemodialysis. The mesylate is PubChem CID 6604561.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 117
Molecular weight 321.17
XLogP 2.02
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES CCOC(=O)c1ccc(cc1)OC(=O)CCCCCN=C(N)N
Isomeric SMILES CCOC(=O)c1ccc(cc1)OC(=O)CCCCCN=C(N)N
InChI InChI=1S/C16H23N3O4/c1-2-22-15(21)12-7-9-13(10-8-12)23-14(20)6-4-3-5-11-19-16(17)18/h7-10H,2-6,11H2,1H3,(H4,17,18,19)
No information available.
Summary of Clinical Use Click here for help
Clinical usage is mainly in Japan and Italy. Gabexate is not FDA approved. See "Continuous regional arterial infusion therapy with gabexate mesilate for severe acute pancreatitis" [2] and related publications.